Chunwang Yuan

机构：Beijing YouAn Hospital · ORCID：0000-0002-4884-3790

发表论文 55 篇 · 总被引 1058 次 · h-index 15

代表论文

• Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001) (2023 · Signal Transduction and Targeted Therapy · 被引 295)
• Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study (2024 · EClinicalMedicine · 被引 156)
• Longitudinal Body Composition Identifies Hepatocellular Carcinoma With Cachexia Following Combined Immunotherapy and Target Therapy (CHANCE2213) (2024 · Journal of Cachexia Sarcopenia and Muscle · 被引 15)
• Predicting hepatocellular carcinoma early recurrence after ablation based on magnetic resonance imaging radiomics nomogram (2022 · Medicine · 被引 15)
• Therapeutic analysis of 632 cases treated by transcatheter arterial chemoembolization combined with ablation in hepatocellular carcinoma: A retrospective study (2024 · European Journal of Radiology · 被引 13)
• Gunagratinib, a highly selective irreversible FGFR inhibitor, in patients with previously treated locally advanced or metastatic cholangiocarcinoma harboring FGFR pathway alterations: A phase IIa dose-expansion study. (2023 · Journal of Clinical Oncology · 被引 11)